🫁 Coming up at #ESMO26: The second Presidential Symposium kicks off at 4:30 CET with the presentation of Krascendo 1 by @FSkoulidis of @UTMDAnderson!

Lung Cancers Today· @Lung_Cancers · X·2026-10-25 21:00· 1 天前评分70

正文 · 原文

➡️ Stay tuned for our coverage and find more #ESMO2026 news here: https://buff.ly/6YOVI22.

#NSCLC #lcsm

34 浏览 · 1 赞 · 0 转发 · 0 回复

会议摘要

2551TIPNCT07541170 NCT07541170 NCT07541170按 NSCLC, early stage 对上

Krascendo 3: A randomised, phase III trial in progress of divarasib vs immunotherapy or observation in patients with resected, stage II-IIIB, KRAS G12C+ non-small cell lung cancer

https://esmocongress.esmo.org

来源：Lung Cancers Today · x.com